NOAEL Studies
Cosmetic Ingredient
Diethyl Succinate NOAEL Studies
INCI: DIETHYL SUCCINATE
CAS: 123-25-1
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS_DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS_DB | NOAEL | 15000 | mg/kg bw/day | mouse | oral | 10 day | Special Toxicology Study | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
NTP_ICE_acute_oral 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP_ICE_acute_oral | LD50 | =8530 | mg/kg bw | Rat | oral | acute | Rat Acute Oral Toxicity | NLM ChemIDplus TEST (undated); record_id=acute_oral_2021; row=4697; data_type=In Vivo; mixture=Chemical; chemical_name=Diethyl butanedioate; preferred_name=Diethyl butanedioate; dtxsid=DTXSID2038732; url=https://chem.nlm.nih.gov/chemidplus/; url_comptox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID2038732; source_file=acute_oral.xlsx |
NTP_ICE_endocrine 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP_ICE_endocrine | Model Score | 0 | unitless | - | - | - | ARPathway2016; AR Pathway Model, Antagonist | sheet=Integrated_approaches; excel_row=7918; RecordID=ARPathway2016_715; DatasetName=ARPathway2016; DTXSID=DTXSID2038732; Assay=AR Pathway Model, Antagonist; Endpoint=Model Score; Response=0; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID2038732 |
NTP_ICE_skin_sensitization 3 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP_ICE_skin_sensitization | Incidence of positive responses | 0 | % | Human | Dermal | - | In Vivo; HPPT2020WIP; Human Maximization Test | sheet=Data_invivo; excel_row=4557; Record_ID=skin_sensitization_invivo_1095; Data_Type=In Vivo; Internal_Data_Source=HPPT2020WIP; Concentration=4.0; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID2038732; Assay=Human Maximization Test; Endpoint=Incidence of positive responses; Response=0; Response_Unit=%; Species=Human; Route=Dermal; Reference=Kligman 1975: report to RIFM|RIFM 1975; https://www.rifm.org/rifm-science-database.php#gsc.tab=0|Anonymous 1978; Not available; 10.1016/S0015-6264(78)80082-0; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID2038732 |
| NTP_ICE_skin_sensitization | Induction dose per skin area | 2700 | ug/cm2 | Human | Dermal | - | In Vivo; HPPT2020WIP; Human Maximization Test | sheet=Data_invivo; excel_row=4555; Record_ID=skin_sensitization_invivo_1095; Data_Type=In Vivo; Internal_Data_Source=HPPT2020WIP; Concentration=4.0; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID2038732; Assay=Human Maximization Test; Endpoint=Induction dose per skin area; Response=2700; Response_Unit=ug/cm2; Species=Human; Route=Dermal; Reference=Kligman 1975: report to RIFM|RIFM 1975; https://www.rifm.org/rifm-science-database.php#gsc.tab=0|Anonymous 1978; Not available; 10.1016/S0015-6264(78)80082-0; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID2038732 |
| NTP_ICE_skin_sensitization | Relative reliability score | 3 | unitless | Human | Dermal | - | In Vivo; HPPT2020WIP; Human Maximization Test | sheet=Data_invivo; excel_row=4561; Record_ID=skin_sensitization_invivo_1095; Data_Type=In Vivo; Internal_Data_Source=HPPT2020WIP; Concentration=4.0; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID2038732; Assay=Human Maximization Test; Endpoint=Relative reliability score; Response=3; Response_Unit=Unitless; Species=Human; Route=Dermal; Reference=Kligman 1975: report to RIFM|RIFM 1975; https://www.rifm.org/rifm-science-database.php#gsc.tab=0|Anonymous 1978; Not available; 10.1016/S0015-6264(78)80082-0; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID2038732 |
openFDA substances 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | ELP55C13DR | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C8H14O4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"ELP55C13DR"} |
| openFDA substances | FDA UNII substance identifier | ELP55C13DR | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C8H14O4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"ELP55C13DR"} |
| openFDA substances | FDA UNII substance identifier | ELP55C13DR | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C8H14O4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"ELP55C13DR"} |
| openFDA substances | FDA UNII substance identifier | ELP55C13DR | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C8H14O4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"ELP55C13DR"} |